We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

38 hedge funds and large institutions have $1.13B invested in Vaxcyte in 2020 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

74.29% more ownership

Funds ownership: 0% → 74.29% (+74%)

Holders
38
Holders Change
+38
Holders Change %
–
% of All Funds
0.78%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.1%
New
38
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$177M
2
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
+$166M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$152M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$151M
5
A
Abingworth
United Kingdom
+$134M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
26
CAAS Capital Management
New York
$632K +$643K +20,000 New
Norges Bank
27
Norges Bank
Norway
$632K +$643K +20,000 New
PCM
28
Pinz Capital Management
New York
$632K +$643K +20,000 New
BFM
29
Boothbay Fund Management
New York
$558K +$567K +17,637 New
Jane Street
30
Jane Street
New York
$423K +$430K +13,380 New
PHK
31
Point72 Hong Kong
Hong Kong
$244K +$248K +7,716 New
CM
32
Crestline Management
Texas
$221K +$225K +7,000 New
PCM
33
Pentwater Capital Management
Florida
$221K +$225K +7,000 New
ECM
34
Endurant Capital Management
California
$216K +$220K +6,827 New
Bank of America
35
Bank of America
North Carolina
$6K +$6.43K +200 New
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$6K +$6.43K +200 New
Morgan Stanley
37
Morgan Stanley
New York
$3K +$3.22K +100 New
SFS
38
Sowell Financial Services
Arkansas
$3K +$3.22K +100 New
1
2

PCVX Hedge Fund Activity: Q2 2020 in Review

38 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q2 2020, worth a combined $1.13B.

Buyers outnumbered sellers: 38 funds opened new PCVX positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $177M.

  • 38 institutional investors held Vaxcyte (PCVX) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $1.13B of Vaxcyte stock for Q2 2020.
  • 38 funds opened new Vaxcyte positions in Q2 2020 and 0 closed out, a net change of +38 holders.
  • The largest Vaxcyte buyer in Q2 2020 was RA Capital Management, an estimated $177M added.

Based on aggregated 13F filings for Q2 2020.